Ganglion cell death in glaucoma: What do we really know?

British Journal of Ophthalmology

Volumn 83, Issue 8, 1999, Pages 980-986

  Osborne, Neville N ^a   Wood, John P M ^a   Chidlow, Glyn ^a   Bae, Ji Hong ^a   Melena, José ^a   Nash, Mark S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

CELL DEATH; GLAUCOMA; HUMAN; NERVE CRUSH; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; VITREOUS BODY;

EID: 0032799037     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.8.980     Document Type: Review

References (65)

1. Osborne NN, Chidlow G, Nash MS, et al. The potential of neuroprotection in glaucoma treatment. Curr Opin Ophthalmol 1999;10:82-92.
2. Neufeld AH. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. J Glaucoma 1998;7:434-8.
3. Koroshetz WJ, Moskowitz M. Emerging treatments for stroke in humans. Trends Pharmacol Sci 1997;17:227-33.
4. Katz B, Wall M. The optic neuropathies. In: Slamovits TL, Burde R, eds. Neuro-ophthalmology. St Louis: Mosby, 1994:Section 2.
5. Rodieck RK, Brening RK. Retinal ganglion cells: properties, types, general pathways and transpecies comparison. Brain Behav Evol 1963;23:121-64.
6. Smiddy WE, Green WR. Nutritional amblyopia: a histopathologic study with retrospective clinical correlation. Graefes Arch Ophthal 1987;225:321-4.
7. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust NZ J Ophthalmol 1995;23:85-91.
8. Quigley HA. Neuronal death in glaucoma. Progr Retinal Eye Res 1998;18:39-57.
9. Glovinsky Y, Quigley HA, Pease ME. Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 1993;34:395-400.
10. Morgan JE. Selective cell death in glaucoma: does it really occur? Br J Ophthalmol 1994;78:875-80.
11. Kalloniatis M, Harwerth RS, Smith EL, et al. Colour vision anomalies following experimental glaucoma in monkeys. Ophthalmic Physics Opt 1993;13:56-67.
12. Weber AJ, Kaufman L, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci 1998;39:2304-20.
13. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma (Suppl) 1994;3:532.
14. Graham S, Drance S, Chauhan B, et al. Comparison of psychophysical and electrophysiological testing in early glaucoma. Invest Ophthalmol Vis Sci 1997;37:497-503.
15. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischaemia and relevance to glaucoma. Surv Ophthalmol 1999;in press.
16. Yoles E, Schwartz M. Potential neuroptotective therapies for glaucomatous optic neuropathy. Surv Ophthalmol 1998;42:367-72.
17. Schwartz M, Belkin M, Yoles E, et al. Potential treatment modalities for glaucomatous neuropathy, neuroprotection and neuroregeneration. J Glaucoma 1996;5:427-32.
18. Hernández MR., Andrzejewska WM, Neufeld AH. Changes in the extracellular matrix of the human optic nerve in primary open angle glaucoma. Am J Ophthalmol 1990;109:180-8.
19. Hernández MR, Pena JDO. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 1997;115:389-95.
20. Neufeld A, Hernández M, González M, et al. Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head. Exp Eye Res 1997;65:739-45.
21. Pena JDO, Taylor AW, Ricard CS, et al. Transforming growth factor β isoforms in human optic nerve heads. Br J Ophthalmol 1999;83:209-18.
22. Neufeld A, Hernandez M, Gozalez M. Nitric oxide synthase in human glaucomatous optic nerve head. Arch Ophthalmol 1997;115:497-503.
23. Anderson DR, Hendrickson A. Effect of intraocular pressure on rapid axonal transport in monkey optic nerve. Invest Ophthalmol 1974;13:771-83.
24. Quigley HA, Guy J, Anderson DR. Blockage of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch Ophthalmol 1979;97:525-31.
25. Quigley HA, Addicks EM, Green WR, et al. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-49.
26. Gupta N, Weinreb RN. New definitions of glaucoma. Curr Opin Ophthalmol 1997;8:38-41.
27. Douglas GR. Pathogenetic mechanisms of glaucoma are not related to intraocular pressure. Curr Opin Ophthalmol 1998;9:34-8.
28. Quigley HA, Dorman-Pease ME, Brown AE. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr Eye Res 1991;10:877-88.
29. Ernest JT. Optic disc blood flow. Trans Ophthalmol Soc UK 1976;96:348-51.
30. Flammer J, Orgül S. Optic nerve blood flow abnormalities in glaucoma. Progr Retinal Eye Res 1998;17:267-89.
31. Silveira LCL, Russelakis-Carneiro M, Perry VH. The ganglion cell response to optic nerve injury in the cat: differential responses revealed by neurofibrillar staining. J Neurocytol 1994;23:75-86.
32. Jacobson M. Developmental neurobiology. New York: Plenum Press, 1991.
33. Sievers J, Hausmann B, Unsicker K, et al. Fibroblast growth factors promote survival of rat retinal ganglion cells after transection of the optic nerve. Neurosci Lett 1987;76:157-62.
34. Carmignoto G, Maffei L, Candeo P, et al. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 1989;9:1763-72.
35. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993;602:304-17.
36. Mansour-Robaey S, Clarke DB, Wang Y-C, et al. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994;91:1632-6.
37. Villegas-Pérez MP, Vidal-Sanz M, Bray GM, et al. Influences of peripheral nerve graft on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci 1988;8:265-80.
38. Aguayo AJ, Rasminsky M, Bray GM. Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals. Phil Trans R Soc Land Biol 1991;331:337-43.
39. Bray GM, Villegas-Pérez MP, Vidal-Sanz M, et al. Neuronal and nonneuronal influences of retinal ganglion cell survival, axonal regrowth, and connectivity after axotomy. Ann NY Acad Sci 1991;633:214-28.
40. Thanos S, Bahr M, Barde Y-A, et al. Survival and axonal elongation of adult rat retinal ganglion cells. Eur J Neurosci 1989;1:19-24.
41. Di Stefano PS, Friedman B, Radziejewski C, et al. The neurotrophins BDNF, NT-3 and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992;8:943-93.
42. Ma Y-T, Hsieh T, Forbes ME, et al. BDNF injected into the superior colliculus reduces development retinal ganglion cell death. J Neurosci 1998;18:2097-107.
43. Cellerino A, Carroll P, Thoenen H, et al. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain derived neurotrophic factor. Mol Cell Neurosci 1997;9:397-408.
44. Brandstätter JH, Hartveit E, Sassoe Pognetto M, et al. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci 1994;6:1100-12.
45. Dreyer EB, Zurakowski D, Schumer RA, et al. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996;114:299-305.
46. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci 1992;8:567-73.
47. Osborne NN. Neuroprotection in the retina: relevance to glaucoma. In: Drance SM, ed. Vascular risk factors and neuroprotection in glaucoma. Kregler Publications, 1997:139-56.
48. Neal MJ, Cunningham JR, Hutson PH, et al. Effects of ischaemia on neurotransmitter release from the isolated retina. J Neurochem 1994;62:1025-33.
49. Siesjo BK. Pathophysiology and treatment of focal cerebral ischaemia. Part II: mechanisms of damage and treatment. J Neurosurg 1992;77:337-54.
50. Siesjo BK. New perspectives in ischaemic brain damage? Progr Brain Res 1993;96:1-9.
51. Galzi JL, Changeux JP. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 1995;34:563-82.
52. Lipton SA. Spontaneous release of acetylcholine affects the physiological nicotinic responses of rat retinal ganglion cells in culture. J Neurosci 1988;8:3857-68.
53. Burgoyne CH. A biomechanical constituent for disc cupping. 1998 ARVO abstract No 1005:5219.
54. DeGirolami U, Zivin JA. Neuropathology of experimental spinal cord ischemia in the rabbit. J Neuropathol Exp Neurol 1992;41:129-49.
55. Wyllie AH, Beattie GJ, Hargreaves AD. Chromatin changes in apoptosis. Histochem J 1981;13:681-92.
56. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
57. Kroemer G, Petit P, Zamzami N, et al. The biochemistry of programmed cell death. Faseb J 1995;9:1277-87.
58. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
59. Russelakis-Carneiro M, Silveira LCL, Perry VH. Factors affecting the survival of cat retinal ganglion cells after optic nerve injury. J Neurocytol 1996;25:393-402.
60. Osborne NN, Cazevieille C, Pergande G, et al. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci 1997;38:1390-400.
61. Charriaut C, Ben-Ari Y. A cautionary note on the TUNEL stain to determine apoptosis. Neuroreport 1995;7:61-4
62. Raffray M, Cohen GM. Apoptosis and necrosis in toxicology: a continuum or distinct modes of death? Pharmacol Ther 1997;75:153-77.
63. Kerrigan LA, Zack DJ, Quigley HA, et al. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997;115:1031-5.
64. Okisaka S, Murakami A, Mizukawa A, et al. Apoptosis in retinal ganglion cells increase in human glaucomatous eyes. Jpn J Ophthalmol 1997;41:84-8.
65. Clarke PGH. Apoptosis versus necrosis. How valid a dichotomy for neurones? In: Koliatsos VE, Ratan RR, eds. Cell death and diseases of the nervous system, 1998:3-28.